Advances in
eISSN: 2377-4290
Submit manuscript...
Case Report Volume 16 Issue 1
Case report: Sustained-release intracameral therapy as an interventional approach in open-angle glaucoma
Jasmine Wang, Mehul Nagarsheth
Received: March 01, 2026 | Published: March 18, 2026
Citation: Wang J, Nagarsheth M. Case report: Sustained-release intracameral therapy as an interventional approach in open-angle glaucoma. Adv Ophthalmol Vis Syst. 2026;16(1):29-31. DOI: 10.15406/aovs.2026.16.00504
Abstract
Topical medications to lower intraocular pressure (IOP) are central to managing glaucoma. However, issues with adherence, damage to the ocular surface, and high costs often limit their effectiveness, especially in elderly patients. Sustained-release intracameral drug delivery systems have emerged as a potential alternative. This report discusses the successful application of iDose TR in a 77-year-old woman with mild-to-moderate open- angle glaucoma who faced significant ocular surface disease and treatment challenges due to topical therapy. After sequential bilateral implantation, the patient maintained stable IOP control, reduced her use of topical medications, and saw a significant improvement in her quality of life.
Keywords: iDose, glaucoma, eye drop, corneal transplantation
©2026 Wang, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.